Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD vs VRD in Newly Diagnosed Multiple Myeloma (DSMM XIV)
NCT01685814Phase 3Unknown
- Start
- May 2012
- Primary completion
- Sep 2016
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of lenalidomide, bortezomib in multiple myeloma (MM). Status: unknown.
02
Drugs
lenalidomidebortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01685814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01685814.